Nonopioid drug for acute pain wins FDA approval Ongoing trials will reveal whether suzetrigine is also effective against chronic pain

A landmark day for pain research! The FDA approved suzetrigine, a NaV1.8 blocker representing the first new class of pain drugs to be approved in over 20 years. #painresearch #suzetrigine #paintherapeutics www.science.org/content/arti... @margolislabnyu.bsky.social